New substance screening platform with neuronal cell networks on chip and novel CNS drugs
Award-winning Neuroproof develops patented novel CNS drugs in the field of neurophatic pain, Alzheimer, Parkinson, Depression and Anxiety thanks to its unique substance test and screening platform. Neuroproof measures the electrical activity of living neuronal cells on a chip to identify and test potential neuropharmaceutical agents, saving considerable time and, above all, money in the preclinical drug discovery process. Neuronal cell cultures and proprietary algorithms support the recognition of anticonvulsants, opiates, pain killers etc.
Investors 1
| Date | Name | Website |
| - | MORE Inves... | more-inves... |